Insider Transactions in Q4 2023 at Aura Biosciences, Inc. (AURA)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 09
2023
|
Matrix Capital Management Company, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,560,000
+18.39%
|
$14,040,000
$9.0 P/Share
|
|
Nov 08
2023
|
David Michael Johnson |
BUY
Open market or private purchase
|
Indirect |
20,000
+11.76%
|
$140,000
$7.3 P/Share
|
|
Nov 08
2023
|
David Michael Johnson |
BUY
Open market or private purchase
|
Direct |
9,601
+6.61%
|
$67,207
$7.3 P/Share
|
|
Nov 07
2023
|
David Michael Johnson |
BUY
Open market or private purchase
|
Indirect |
94,000
+41.96%
|
$658,000
$7.17 P/Share
|
|
Nov 07
2023
|
David Michael Johnson |
BUY
Open market or private purchase
|
Direct |
76,000
+37.61%
|
$532,000
$7.17 P/Share
|
|
Nov 06
2023
|
Pinos Elisabet De Los |
SELL
Open market or private sale
|
Direct |
7,449
-4.03%
|
$89,388
$12.03 P/Share
|
|
Nov 06
2023
|
Pinos Elisabet De Los |
BUY
Exercise of conversion of derivative security
|
Direct |
3,800
+2.02%
|
$7,600
$2.74 P/Share
|
|
Nov 06
2023
|
Julie B Feder Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,900
-5.31%
|
$46,800
$12.07 P/Share
|
|
Nov 06
2023
|
Julie B Feder Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,900
+5.04%
|
$7,800
$2.74 P/Share
|
|
Nov 01
2023
|
Janet Jill Hopkins Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
135,000
+50.0%
|
-
|
|
Oct 30
2023
|
Pinos Elisabet De Los |
SELL
Open market or private sale
|
Direct |
9,586
-5.03%
|
$57,516
$6.83 P/Share
|
|
Oct 30
2023
|
Julie B Feder Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,385
-4.64%
|
$20,310
$6.82 P/Share
|
|
Oct 04
2023
|
David Michael Johnson |
BUY
Open market or private purchase
|
Direct |
6,566
+11.59%
|
$52,528
$8.61 P/Share
|
|
Oct 03
2023
|
David Michael Johnson |
BUY
Open market or private purchase
|
Direct |
13,500
+23.68%
|
$108,000
$8.27 P/Share
|